Glow LifeTech (DE:9DO)
FRANKFURT:9DO
9DO Stock Chart & Stats
€0.02
€0.00(0.00%)
At close: 4:00 PM EST
€0.02
€0.00(0.00%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.05
Previous CloseN/A
Volume0.00
Average Volume (3M)83.00
Market Cap
€5.35M
Enterprise Value€7.11M
Total Cash (Recent Filing)€1.59M
Total Debt (Recent Filing)€45.48K
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,235,550
10 Day Avg. Volume0
30 Day Avg. Volume83
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRevenue accelerated materially (TTM growth ~86%), showing expanding commercial traction and product adoption. Sustained top-line growth provides a larger base to absorb fixed costs and supports eventual scale-driven margin improvement over the next several quarters.
Material FCF ImprovementFree cash flow has moved meaningfully toward breakeven, indicating improving operating efficiency and lower incremental burn. If this trend persists, the company will need less external financing and gain more runway to invest in growth and R&D sustainably.
Low LeverageVery low debt provides financial flexibility to fund ongoing R&D and commercial expansion without heavy interest burdens. Low leverage reduces short-term solvency risk and creates capacity to raise capital on better terms if needed.
Bears Say
Ongoing Cash BurnNegative operating and free cash flow indicate the business still consumes cash to operate. Continued burn forces reliance on external funding or reserves; adverse funding conditions or execution setbacks could pressure operations and dilute shareholders.
Sustained UnprofitabilityThe company remains in a heavy investment/burn phase with negative operating profit and EBITDA. Without a clear, sustained move to positive operating earnings, converting revenue growth into durable profits remains uncertain and heightens execution risk.
Balance-sheet Volatility HistoryPast episodes of negative equity signal material downside risk if losses recur. Historical balance-sheet volatility increases the probability of future dilution, restructuring, or financing stress if operational improvements stall.
Glow LifeTech News
9DO FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was <€0.01 and its highest was €0.05 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is €5.35M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 81 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,235,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in DE:9DO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―
Options Prices
Currently, No data available
---